In a 21‑week pregnant patient with a thyroid‑stimulating hormone (TSH) <0.01 mIU/L and normal free thyroxine (free T4) on repeated tests, when should hyperthyroidism be considered?

When to Consider Hyperthyroidism in Pregnancy with TSH <0.01 and Normal Free T4

In a 21-week pregnant patient with repeatedly suppressed TSH (<0.01 mIU/L) and normal free T4, this represents subclinical hyperthyroidism that does NOT require treatment and is NOT associated with adverse pregnancy outcomes 1.

Diagnostic Framework

Understanding TSH Suppression in Pregnancy

TSH suppression is physiologically normal during pregnancy, particularly in the first trimester, due to the TSH-like effects of human chorionic gonadotropin (hCG) 2. The key distinction is:

• Isolated low TSH with normal free T4 = Subclinical hyperthyroidism
• Low TSH with elevated free T4 = Overt hyperthyroidism requiring evaluation and treatment

When to Diagnose True Hyperthyroidism

Consider true hyperthyroidism requiring intervention when:

1. Free T4 is elevated above pregnancy-specific reference ranges (not just normal) 2, 3

2. Clinical features are present:

   • Goiter with bruit or thrill
   • Persistent tachycardia beyond normal pregnancy
   • Significant weight loss despite adequate intake
   • Severe hyperemesis gravidarum (5% weight loss, dehydration, ketonuria) 2

3. Additional confirmatory testing shows:

   • Elevated free T3 levels
   • TSH receptor antibodies (TRAb) elevated 2-3 fold above normal 2
   • Thyroid peroxidase antibodies present

Critical Distinction: Your Patient's Scenario

Your patient at 21 weeks with TSH <0.01 and normal free T4 has subclinical hyperthyroidism, which:

• Occurs in 1.7% of pregnancies 1
• Is NOT associated with adverse pregnancy outcomes 1
• Does NOT require treatment 1
• Actually shows reduced risk of hypertensive complications (adjusted OR 0.66) 1

Common Pitfall to Avoid

Do not overtreat based on TSH alone. TSH levels beyond the normal range do not reliably reflect abnormal thyroid hormone levels during pregnancy 4. The physiologic TSH suppression from hCG can persist throughout pregnancy, and TSH may remain low even with appropriate treatment 3.

Management Algorithm for This Patient

For isolated TSH suppression with normal free T4:

1. No antithyroid drug treatment needed 1
2. Monitor thyroid function every 4-6 weeks to ensure free T4 remains normal
3. Assess for clinical signs of true hyperthyroidism at each visit
4. Measure TRAb if there is any history of Graves' disease (past or current) to assess fetal risk 2

Escalate to treatment ONLY if:

• Free T4 becomes elevated above pregnancy-specific upper limit
• Clinical hyperthyroidism develops
• TRAb levels are significantly elevated (>3x upper normal limit) suggesting risk of fetal hyperthyroidism 2

When Overt Hyperthyroidism Requires Treatment

If free T4 were elevated (which it is not in your case), treatment goals would be:

• Keep maternal free T4 in the upper range of normal (not mid-range) 3
• Use propylthiouracil in first trimester, then switch to methimazole 2, 3
• Monitor every 2-4 weeks 3
• TSH may remain suppressed despite adequate treatment—use free T4 for monitoring, not TSH 3

Your patient does not meet criteria for treatment and should be reassured that subclinical hyperthyroidism in pregnancy is benign 1.